Abelaphar SRL
The score of Abelaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Abelaphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Abelaphar's financial analysis
- Solvency20.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Abelaphar
Abelaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0808.709.586
- VAT number
- BE0808709586
- Peppol
- Registered · 0208:0808709586 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Dec 2008
- Registered office
- 2880 Bornem
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Abelaphar (SRL) has been based in Bornem since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 72 € and equity of 36,346 €; its revenue is not published. Its solvency stands at 20.4%, below the median of its sector (44.2%).
Companies similar to Abelaphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie WAGMANS-CREMA Retail sale of pharmaceutical products Dalhem · balance sheet 167,379 €
- Ilse Verstraeten Retail sale of pharmaceutical products Sint-Truiden · balance sheet 178,548 €
- Apotheek D'Hondt Pascal Retail sale of pharmaceutical products Lokeren · balance sheet 177,633 €
- Hilde Braeken Retail sale of pharmaceutical products Hasselt · balance sheet 180,493 €
- Emilie Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,476 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Naturotheek Lindenbos Retail sale of other food Aartselaar · balance sheet 170,770 €
Frequently asked questions about Abelaphar
What is the revenue of Abelaphar?
Abelaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Abelaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0808709586 for Abelaphar, if the company is VAT-registered. Its company number (CBE) is 0808.709.586.
Where is the registered office of Abelaphar?
According to the CBE register, the registered office of Abelaphar is in 2880 Bornem.
What is the equity of Abelaphar?
At the close of the 2025 financial year, the equity of Abelaphar amounts to 36,346 €, a solvency of 20.4% of total assets.
Who manages Abelaphar?
The register lists 3 active mandates at Abelaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Abelaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →